These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15885781)

  • 21. Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection.
    Kovacs K; Wagley S; Quirk MT; Ceron OM; Silva PA; Singh RJ; Gukasyan HJ; Arroyo JG
    Am J Ophthalmol; 2012 May; 153(5):939-48. PubMed ID: 22310078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis.
    Tanner V; Kanski JJ; Frith PA
    Eye (Lond); 1998; 12 ( Pt 4)():679-85. PubMed ID: 9850264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous hypopigmentation following a posterior sub-tenon triamcinolone injection.
    Gallardo MJ; Johnson DA
    Am J Ophthalmol; 2004 Apr; 137(4):779-80. PubMed ID: 15059734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ptosis following an intravitreal injection of triamcinolone acetonide.
    Viola F; Morescalchi F; Ratiglia R; Staurenghi G
    Eye (Lond); 2007 Mar; 21(3):421-3. PubMed ID: 16498434
    [No Abstract]   [Full Text] [Related]  

  • 26. Ptosis after intravitreal injection of triamcinolone acetonide: a retrospective case series.
    Minnella AM; Falsini B; Petroni S; Montrone L; Zinzanella G; Bamonte G; Balestrazzi E
    Ophthalmologica; 2007; 221(5):363. PubMed ID: 17728561
    [No Abstract]   [Full Text] [Related]  

  • 27. Cataract progression after intravitreal triamcinolone injection.
    Cekiç O; Chang S; Tseng JJ; Akar Y; Barile GR; Schiff WM
    Am J Ophthalmol; 2005 Jun; 139(6):993-8. PubMed ID: 15953428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proptosis after retrobulbar corticosteroid injections.
    Gupta OP; Boynton JR; Sabini P; Markowitch W; Quatela VC
    Ophthalmology; 2003 Feb; 110(2):443-7. PubMed ID: 12578795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic absorption of triamcinolone acetonide after posterior sub-Tenon injection.
    Zaka-ur-Rab S; Mahmood S; Shukla M; Zakir SM; Khan BA; Owais M
    Am J Ophthalmol; 2009 Sep; 148(3):414-9. PubMed ID: 19464668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orbital infection following posterior subtenon triamcinolone injection.
    Kusaka S; Ikuno Y; Ohguro N; Hori Y; Tano Y
    Acta Ophthalmol Scand; 2007 Sep; 85(6):692-3. PubMed ID: 17590202
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Floretlike cells in in situ and prolapsed orbital fat.
    Ebrahimi KB; Ren S; Green WR
    Ophthalmology; 2007 Dec; 114(12):2345-9. PubMed ID: 17822769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous subconjunctival orbital fat prolapse: presentation of four cases.
    Stangos AN; Hamédani M
    Klin Monbl Augenheilkd; 2006 May; 223(5):415-7. PubMed ID: 16705519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS; Vernon SA; Negi A
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
    Hirano Y; Sakurai E; Yoshida M; Ogura Y
    Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
    Paganelli F; Cardillo JA; Melo LA; Lucena DR; Silva AA; Oliveira AG; Höfling-Lima AL; Nguyen QD; Kuppermann BD; Belfort R;
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3041-7. PubMed ID: 19234342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.